Tudor Investment Corp ET AL cut its holdings in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Free Report) by 47.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,873 shares of the company's stock after selling 18,682 shares during the period. Tudor Investment Corp ET AL owned approximately 0.06% of Crescent Capital BDC worth $401,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in the business. Franklin Resources Inc. lifted its position in shares of Crescent Capital BDC by 12.8% in the 4th quarter. Franklin Resources Inc. now owns 289,131 shares of the company's stock valued at $5,557,000 after acquiring an additional 32,852 shares in the last quarter. Condor Capital Management raised its holdings in shares of Crescent Capital BDC by 4.7% during the fourth quarter. Condor Capital Management now owns 284,055 shares of the company's stock worth $5,460,000 after acquiring an additional 12,852 shares in the last quarter. Wells Fargo & Company MN increased its position in Crescent Capital BDC by 0.5% in the 4th quarter. Wells Fargo & Company MN now owns 253,182 shares of the company's stock worth $4,866,000 after purchasing an additional 1,210 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Crescent Capital BDC during the 4th quarter worth about $3,750,000. Finally, Denali Advisors LLC lifted its holdings in shares of Crescent Capital BDC by 0.5% during the 4th quarter. Denali Advisors LLC now owns 183,783 shares of the company's stock valued at $3,532,000 after buying an additional 855 shares during the last quarter. 49.46% of the stock is currently owned by institutional investors.
Crescent Capital BDC Stock Performance
CCAP traded down $0.53 during midday trading on Thursday, reaching $16.13. The company's stock had a trading volume of 101,241 shares, compared to its average volume of 140,385. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. The company has a fifty day simple moving average of $16.25 and a 200 day simple moving average of $18.11. The stock has a market cap of $597.78 million, a P/E ratio of 8.11 and a beta of 0.63. Crescent Capital BDC, Inc. has a twelve month low of $13.54 and a twelve month high of $20.19.
Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its earnings results on Wednesday, May 14th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.52 by ($0.07). The company had revenue of $42.13 million for the quarter, compared to the consensus estimate of $45.08 million. Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. Research analysts expect that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current year.
Crescent Capital BDC Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Monday, June 30th will be issued a dividend of $0.42 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $1.68 annualized dividend and a dividend yield of 10.42%. Crescent Capital BDC's payout ratio is 84.42%.
Wall Street Analysts Forecast Growth
CCAP has been the topic of several recent research reports. Keefe, Bruyette & Woods cut their price objective on shares of Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating on the stock in a research report on Tuesday, April 8th. Wells Fargo & Company reduced their target price on Crescent Capital BDC from $18.00 to $16.00 and set an "equal weight" rating for the company in a report on Monday, April 28th.
Read Our Latest Research Report on Crescent Capital BDC
Crescent Capital BDC Profile
(
Free Report)
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also

Before you consider Crescent Capital BDC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.
While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.